Health Care • Medical/Dental Instruments
$31.52 ▲ +0.72
(+2.34%)
MKT CAP: $823.0M • VOL: 835.0K
52W L $14 52W H $33
KIDS // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $236.3M | $204.7M | $148.7M |
| YoY Revenue Growth % | +15.4% | +37.6% | — |
| Gross Profit | $172.7M | $148.6M | — |
| Gross Margin % | 73.1% | 72.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$39.2M | -$35.0M | -$26.8M |
| Operating Margin % | -16.6% | -17.1% | -18.0% |
| Net Income (GAAP) | -$39.6M | -$37.8M | -$21.0M |
| EBITDA (Normalized) | -$30.4M | -$23.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$4.9M | -$27.0M | -$27.0M |
| Capital Expenditures (CapEx) | $11.1M | $14.3M | — |
| Free Cash Flow (FCF) | -$16.0M | -$41.3M | -$27.0M |
| FCF Margin % | -6.8% | -20.2% | -18.2% |
| Return on Invested Capital (ROIC %) | -7.3% | -7.2% | — |
| Cash & Short-Term Equivalents | $19.6M | $43.8M | — |
| Total Debt (Short + Long Term) | $99.8M | $73.0M | — |
| Total Stockholders' Equity | $346.6M | $354.6M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR KIDS.